Delivery Order SPE2DX22D0069-SPE2D826F03C2
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,353.67 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a non-set-aside award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,304.88 by the Defense Logistics Agency's Medical Supply Chain on October 2, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,379.98 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and serves as a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,699.50 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. This firm fixed-price delivery order, with a completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $121,726.44 by the Defense Logistics Agency's Medical Supply Chain, with a firm fixed price contract type and completion target of September 2, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $57,029.60 by the Defense Logistics Agency's Medical Supply Chain. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,379.98 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,371.30 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,279.84 on September 15, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DX22D0069Indefinite Delivery Contract
- SPE2DX22D0069-SPE2D826F03C2Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $551,900.70 by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of November 12, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order aligns with the company's established role as a critical pharmaceutical vendor supplying the Department of Defense and federal healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement, which authorizes the company to supply a wide range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. The Defense Logistics Agency is implementing a Pharmaceutical Prime Vendor Global Program Generation V strategy designed to award multiple contracts across separate regions, positioning AmerisourceBergen alongside other qualified contractors to serve the Defense Health Agency, U.S. Coast Guard, and additional government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $551.9k | 11/10/25 |